Published May 9, 2021, 6:48 AM
Over a year after the coronavirus disease (COVID-19) pandemic caught the world by surprise, countries and institutions – both local and international – continue to grapple with impact of the health crisis.
The Philippine Red Cross, under the leadership of its Chairman and CEO Senator Richard J. Gordon, continues to serve the most vulnerable even with limited resources. (Photo from Philippine Red Cross)
Despite the challenges, certain institutions continue to cope with the changes brought by the pandemic. In the country, for instance, the Philippine Red Cross (PRC) has been at the forefront in the fight against COVID-19 – revolutionizing how to respond to a humanitarian crisis of this magnitude.
About OneNews
OneNews.PH is the online presence of OneNews, the all-news channel of Cignal TV and the synergy of the journalistic strengths of The Philippine STAR, philstar.com, TV5 Network Inc. and BusinessWorld under Mediaquest Holdings Inc.
About Leronlimab (PRO 140)
Leronlimab has been studied in 11 clinical trials involving more than 1,200 people and met its primary endpoints in a pivotal Phase 3 trial (leronlimab combined with standard antiretroviral therapies in HIV-infected treatment-experienced patients).
Leronlimab is a viral-entry inhibitor in HIV/AIDS. It masks CCR5, thus protecting healthy T cells from viral infection by blocking the predominant HIV (R5) subtype from entering those cells. Nine clinical trials have demonstrated leronlimab could significantly reduce or control HIV viral load in humans. The leronlimab antibody appears to be a powerful antiviral agent with fewer side effects and less frequent dosing requirements than currently used daily drug therapi
BusinessWorld
May 9, 2021 | 11:05 pm
SHARES are expected to correct this trading week as investors await the release of the first quarter (Q1) gross domestic product (GDP) report.
The Philippine Stock Exchange (PSEi) declined by 24.07 points or 0.38% to close at 6,258.71 on Friday, while the broader all shares index went down by 2.22 points or 0.05% to finish at 3,877.43.
Week on week, the benchmark index likewise shed 112.16 points from its 6,370.87 close on April 30.
Timson Securities, Inc. Trader Darren Blaine T. Pangan said inflation concerns here and abroad continued to cloud investor sentiment.
“Locally, trading volume remained thin, as investors digested the many economic reports released such as the April manufacturing activity, as well as April’s inflation rate,” Mr. Pangan said in a Viber message on Saturday.
Philippine COVID-19 infections top 1.1 million
May 9, 2021 | 7:53 pm
RESIDENTS of Old Balara go to Old Balara Elementary school during the continuation of the vaccination program for the A1 to A3 categories on May 3. PHILIPPINE STAR/ MICHAEL VARCAS
THE DEPARTMENT of Health (DoH) reported 7,174 coronavirus infections on Sunday, bringing the total to 1.1 million.
The death toll rose by 204 to 18,472, while recoveries increased by 9,197 to 1.02 million, it said in a bulletin.
There were 61,294 active cases, 1.3% of which were critical, 93.8% were mild, 2.1% did not show symptoms, 1.7% were severe and 1.07% were moderate.
DoH said 33 duplicates had been removed from the tally, 28 of which were tagged as recoveries and one as death. It added that 149 recoveries were reclassified as deaths.